We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FOXA icon
1301
Fox Class A
FOXA
$27.7B
$261K ﹤0.01%
4,165
+2,617
+169% +$163K
2025 Q1
6 quarters
GUACW icon
1302
Berto Acquisition Corp II Warrants
GUACW
$3.5M
$260K ﹤0.01%
+433,332
New +$277K
2026 Q3
0 quarters
AR icon
1303
Antero Resources
AR
$11.3B
$260K ﹤0.01%
7,774
-416,765
-98% -$15M
2025 Q1
6 quarters
ALMS icon
1304
Alumis
ALMS
$570M
$259K ﹤0.01%
+35,000
New +$725K
2026 Q3
0 quarters
PTC icon
1305
PTC
PTC
$21.3B
$259K ﹤0.01%
+1,843
New +$253K
2026 Q3
0 quarters
CHE icon
1306
Chemed
CHE
$7.09B
$257K ﹤0.01%
+509
New +$263K
2026 Q3
0 quarters
TKO icon
1307
TKO Group
TKO
$13.8B
$256K ﹤0.01%
1,425
-13,575
-91% -$2.56M
2026 Q1
2 quarters
IRHOR icon
1308
Iron Horse Acquisitions Corp II Rights
IRHOR
$255K ﹤0.01%
+1,500,000
New +$258K
2026 Q3
0 quarters
HQWWW icon
1309
Horizon Quantum Holdings Warrant
HQWWW
$21.9M
$254K ﹤0.01%
38,266
+1,144
+3% +$8.78K
2026 Q1
2 quarters
BDX icon
1310
Becton Dickinson
BDX
$58.9B
$254K ﹤0.01%
1,421
-7,474
-84% -$1.3M
2026 Q1
2 quarters
SGI icon
1311
Somnigroup International
SGI
$14.4B
$251K ﹤0.01%
4,041
-4,197
-51% -$284K
2026 Q2
1 quarter
VBNK icon
1312
VersaBank
VBNK
$251K ﹤0.01%
+11,281
New +$236K
2026 Q3
0 quarters
BMEA icon
1313
Biomea Fusion
BMEA
$38.5M
$247K ﹤0.01%
200,000
– –
2025 Q4
3 quarters
YUM icon
1314
Yum! Brands
YUM
$43.1B
$245K ﹤0.01%
+1,796
New +$269K
2026 Q3
0 quarters
RTACW icon
1315
Renatus Tactical Acquisition Corp I Warrant
RTACW
$1.96M
$243K ﹤0.01%
450,000
– –
2025 Q2
5 quarters
PHM icon
1316
Pultegroup
PHM
$23B
$243K ﹤0.01%
+2,092
New +$263K
2026 Q3
0 quarters
CRBP icon
1317
Corbus Pharmaceuticals
CRBP
$56.7M
$242K ﹤0.01%
35,500
– –
2026 Q2
1 quarter
IONS icon
1318
CALL
Ionis Pharmaceuticals
IONS
$4.56B
$241K ﹤0.01%
5,400
– –
2026 Q2
1 quarter
IDA icon
1319
Idacorp
IDA
$8.45B
$239K ﹤0.01%
+1,825
New +$257K
2026 Q3
0 quarters
ECO icon
1320
Okeanis Eco Tankers
ECO
$3.23B
$237K ﹤0.01%
+2,930
New +$191K
2026 Q3
0 quarters
MDAIW icon
1321
Spectral AI Warrants
MDAIW
$3.52M
$237K ﹤0.01%
503,694
– –
2024 Q4
7 quarters
DHI icon
1322
D.R. Horton
DHI
$39.2B
$235K ﹤0.01%
+1,720
New +$251K
2026 Q3
0 quarters
TTC icon
1323
Toro Company
TTC
$9.8B
$234K ﹤0.01%
+2,432
New +$233K
2026 Q3
0 quarters
ALFUW icon
1324
Centurion Acquisition Corp Warrant
ALFUW
$1.62M
$234K ﹤0.01%
937,500
– –
2024 Q4
7 quarters
BRTMW
1325
B&R Technology Merger Corp Warrants
BRTMW
$234K ﹤0.01%
+750,000
New +$237K
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.